Tech Company Financing Transactions
SteadyMed Therapeutics Funding Round
SteadyMed Therapeutics, based in San Ramon, received $10.4 million from KB Partners, Samson Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/18/2012
Transaction Type
Venture Equity
Amount
$10,400,000
Round
Undisclosed
Investors
KB Partners (Keith Bank)
Proceeds Purpose
Proceeds from the financing will be used to support the development and commercialization of the company's lead drug product that leverages its PatchPump® technology; a novel, prefilled, size efficient and disposable subcutaneous drug delivery system for which the company aims to complete pivotal clinical trials in 2013 followed by commercial launch in the U.S. in 2014. Proceeds will also be used to complete the outsourced manufacturing infrastructure to support the company's commercialization strategy.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2603 Camino Ramon 350
San Ramon, CA 94583
USA
San Ramon, CA 94583
USA
Phone
Website
Email Address
Not Recorded
Overview
SteadyMed Therapeutics (NASDAQ: STDY) is a drug delivery therapeutics company. We are leaders in the development and commercialization of prefilled, size efficient and disposable patch pump technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Rigby
Chief Financial Officer
David Nassif
Chief Medical Officer
Jeff Myers
VP - Operations
Robert Zwolinski
Browse more venture capital transactions:
Prev: 9/18/2012: Silver Spring Networks venture capital transaction
Next: 9/18/2012: GENWI venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs